These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Designing Chimeric Virus-like Particle-based Vaccines for Human Papillomavirus and HIV: Lessons Learned. Eto Y; Saubi N; Ferrer P; Joseph J AIDS Rev; 2019; 21(4):218-232. PubMed ID: 31834327 [TBL] [Abstract][Full Text] [Related]
6. Immune responses to human papillomavirus. Stanley M Vaccine; 2006 Mar; 24 Suppl 1():S16-22. PubMed ID: 16219398 [TBL] [Abstract][Full Text] [Related]
7. Immune responses to HIV vaccines and potential impact on control of acute HIV-1 infection. McElrath MJ J Infect Dis; 2010 Oct; 202 Suppl 2(Suppl 2):S323-6. PubMed ID: 20846040 [TBL] [Abstract][Full Text] [Related]
8. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. Garnett GP J Infect Dis; 2005 Feb; 191 Suppl 1():S97-106. PubMed ID: 15627236 [TBL] [Abstract][Full Text] [Related]
9. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis? Beckebaum S; Cicinnati VR; Gerken G Rev Med Virol; 2002; 12(5):297-319. PubMed ID: 12211043 [TBL] [Abstract][Full Text] [Related]
10. Update on HIV vaccines. Meldorf M; Corey L STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929 [TBL] [Abstract][Full Text] [Related]
11. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses. Inchauspé G; Michel ML J Viral Hepat; 2007 Nov; 14 Suppl 1():97-103. PubMed ID: 17958650 [TBL] [Abstract][Full Text] [Related]
12. A new insight into hepatitis C vaccine development. Yu CI; Chiang BL J Biomed Biotechnol; 2010; 2010():548280. PubMed ID: 20625493 [TBL] [Abstract][Full Text] [Related]
13. ALVAC-HIV vaccines: clinical trial experience focusing on progress in vaccine development. Marovich MA Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S99-104. PubMed ID: 15285709 [TBL] [Abstract][Full Text] [Related]
14. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection. Stanley MA Expert Rev Vaccines; 2003 Jun; 2(3):381-9. PubMed ID: 12903803 [TBL] [Abstract][Full Text] [Related]
15. Particle-based vaccines for HIV-1 infection. Young KR; Ross TM Curr Drug Targets Infect Disord; 2003 Jun; 3(2):151-69. PubMed ID: 12769792 [TBL] [Abstract][Full Text] [Related]
16. Strategies for the prevention of cervical cancer by human papillomavirus vaccination. Williamson AL; Passmore JA; Rybicki EP Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 immunogen (remune). Newsline People AIDS Coalit N Y; 1998 Dec; ():36. PubMed ID: 11367099 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented? Shaw AR Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S246-8. PubMed ID: 16213009 [TBL] [Abstract][Full Text] [Related]